Institutional Ownership Acrivon Therapeutics, Inc. (ACRV)
This table provides information about the institutional ownership of Acrivon Therapeutics, Inc. (ACRV). We have compiled data on the 59 institutions that hold shares in the stock, with a total of 23.3 Million shares, which have been reported (via 13F filing form) to have a value of $0.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Ra Capital Management, L.P.
Boston, MA |
Feb 14, 2025 Q4 2024 |
8,340,508
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|
|
|
Perceptive Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
5,360,858
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 78.23%
|
|
|
Sands Capital Ventures, LLC
Arlington, VA |
Feb 13, 2025 Q4 2024 |
2,122,605
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 28.44%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
2,119,646
shares
|
$0
0.0% of portfolio
|
Q4 2024
Reduced 0.98%
|
|
|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
888,130
shares
|
$0
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
767,020
shares
|
$0
0.0% of portfolio
|
Q2 2024
Added 3.11%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
671,625
shares
|
$0
0.0% of portfolio
|
Q4 2024
Added 5.35%
|
|
|
Marshall Wace, LLP
London, X0 |
Feb 13, 2025 Q4 2024 |
597,794
shares
|
$0
0.0% of portfolio
|
Q4 2024
Reduced 26.19%
|
|
|
Acorn Capital Advisors, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
405,237
shares
|
$0
1.32% of portfolio
|
Q4 2024
New holding
|
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
301,389
shares
|
$0
0.0% of portfolio
|
Q4 2024
Reduced 0.24%
|
|
|
Health Cor Management, L.P.
New York, NY |
Feb 14, 2023 Q4 2022 |
284,201
shares
|
$0
0.0% of portfolio
|
Q4 2022
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
237,552
shares
|
$0
0.0% of portfolio
|
Q4 2024
Added 19.87%
|
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
236,601
shares
|
$0
0.0% of portfolio
|
Q4 2024
Added 4.74%
|
|
|
Northern Trust Corp
Chicago, IL |
Feb 14, 2025 Q4 2024 |
117,323
shares
|
$0
0.0% of portfolio
|
Q4 2024
Added 11.31%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Feb 06, 2025 Q4 2024 |
113,840
shares
|
$0
0.0% of portfolio
|
Q4 2024
Reduced 2.08%
|
|
|
Dafna Capital Management LLC
Los Angeles, CA |
Feb 14, 2025 Q4 2024 |
112,414
shares
|
$0
0.0% of portfolio
|
Q3 2024
Reduced 7.36%
|
|
|
Ubs Oconnor LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
102,784
shares
|
$0
0.0% of portfolio
|
Q4 2024
Added 29.7%
|
|
|
Bridgeway Capital Management, LLC
Houston, TX |
Feb 14, 2025 Q4 2024 |
74,600
shares
|
$0
0.0% of portfolio
|
Q4 2024
Reduced 3.09%
|
|
|
Baker Bros. Advisors LP
New York, NY |
Feb 14, 2025 Q4 2024 |
52,885
shares
|
$0
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
49,400
shares
|
$0
0.0% of portfolio
|
Q4 2024
Added 7.63%
|
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
38,091
shares
|
$0
0.0% of portfolio
|
Q4 2024
Added 14.37%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
37,063
shares
|
$0
0.0% of portfolio
|
Q4 2024
Added 20.24%
|
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
34,731
shares
|
$0
0.0% of portfolio
|
Q4 2024
Reduced 3.29%
|
|
|
Bank Of America Corp
Charlotte, NC |
Feb 14, 2025 Q4 2024 |
31,106
shares
|
$0
0.0% of portfolio
|
Q4 2024
Added 3.81%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
25,809
shares
|
$0
0.0% of portfolio
|
Q4 2024
Reduced 24.07%
|